Clinical Trial Update: Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Cardiac Antioxidant/Anti-inflammatory Profile Before Cardiac Surgery [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluating whether Lovaza omega-3 fatty acids can improve cardiac antioxidant and anti-inflammatory profiles in patients undergoing cardia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Valve Regurgitation
• Myocarditis

Drugs mentioned

• LOVAZA (OMEGA-3-ACID ETHYL ESTERS)

Snippet

Sponsor: East Carolina University | Conditions: Mitral Valve Regurgitation, Left Atrium Dilatation and Hypertrophy | Phase 4 | Status: UNKNOWN